Jielai Xia

4.8k total citations · 1 hit paper
83 papers, 1.6k citations indexed

About

Jielai Xia is a scholar working on Statistics and Probability, Epidemiology and Hepatology. According to data from OpenAlex, Jielai Xia has authored 83 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Statistics and Probability, 21 papers in Epidemiology and 17 papers in Hepatology. Recurrent topics in Jielai Xia's work include Statistical Methods in Clinical Trials (19 papers), Optimal Experimental Design Methods (9 papers) and Liver Disease and Transplantation (9 papers). Jielai Xia is often cited by papers focused on Statistical Methods in Clinical Trials (19 papers), Optimal Experimental Design Methods (9 papers) and Liver Disease and Transplantation (9 papers). Jielai Xia collaborates with scholars based in China, United States and Taiwan. Jielai Xia's co-authors include Ling Wang, Daiming Fan, Hong Cai, Zhanxin Yin, Chanjuan Li, Guohong Han, Jing Niu, Chuangye He, Kaichun Wu and Zhiwei Jiang and has published in prestigious journals such as PLoS ONE, Circulation Research and Hepatology.

In The Last Decade

Jielai Xia

78 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Longterm Exercise-Derived Exosomal miR-342-5p

2019 243 citations Jielai Xia et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jielai Xia China	21	487	458	444	275	238	83	1.6k
Nicole S. Erler Netherlands	26	507 1.0×	187 0.4×	383 0.9×	144 0.5×	50 0.2×	85	1.7k
Irene M. Shui United States	26	601 1.2×	78 0.2×	204 0.5×	311 1.1×	123 0.5×	67	2.2k
Elena Myasoedova United States	25	371 0.8×	230 0.5×	297 0.7×	363 1.3×	489 2.1×	102	3.5k
Bonnie Lau United States	16	226 0.5×	56 0.1×	215 0.5×	455 1.7×	167 0.7×	34	1.8k
Zhichao Jin China	20	221 0.5×	136 0.3×	196 0.4×	251 0.9×	57 0.2×	57	1.2k
Dawei Wu China	26	351 0.7×	73 0.2×	486 1.1×	527 1.9×	166 0.7×	111	2.1k
Sylvain Mathieu France	26	198 0.4×	77 0.2×	337 0.8×	295 1.1×	146 0.6×	92	2.4k
Tisha Joy Canada	21	418 0.9×	69 0.2×	635 1.4×	532 1.9×	213 0.9×	39	1.7k
Fen Liu China	21	377 0.8×	198 0.4×	276 0.6×	296 1.1×	264 1.1×	154	1.7k

Countries citing papers authored by Jielai Xia

Since Specialization

Citations

This map shows the geographic impact of Jielai Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jielai Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jielai Xia more than expected).

Fields of papers citing papers by Jielai Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jielai Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jielai Xia. The network helps show where Jielai Xia may publish in the future.

Co-authorship network of co-authors of Jielai Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Jielai Xia. A scholar is included among the top collaborators of Jielai Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jielai Xia. Jielai Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xue, Min, Jielai Xia, Xuewu Zhu, et al.. (2025). Knowledge, attitudes, and practices toward osteoporosis: a questionnaire survey. Frontiers in Public Health. 13. 1621402–1621402.

Wang, Wenwen, et al.. (2024). Mendelian randomization analyses of known and suspected risk factors and biomarkers for myasthenia gravis overall and by subtypes. BMC Neurology. 24(1). 33–33.

Qi, Yangyang, Jinxia Wang, Yani Chen, et al.. (2024). Safety, Immunogenicity, and Effectiveness of Chinese-Made COVID-19 Vaccines in the Real World: An Interim Report of a Living Systematic Review. Vaccines. 12(7). 781–781. 1 indexed citations

Wang, Wenwen, Wenli Zhang, Manli Huang, et al.. (2024). The crucial prognostic signaling pathways of pancreatic ductal adenocarcinoma were identified by single-cell and bulk RNA sequencing data. Human Genetics. 143(9-10). 1109–1129. 1 indexed citations

Huang, Lirong, Lingyun Zhou, Li Shi, et al.. (2023). Safety and immunogenicity of a pichia pastoris-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine in healthy Chinese women aged 9–45 years: A randomized, double-blind, placebo-controlled phase 1 clinical trial. Vaccine. 41(19). 3141–3149. 7 indexed citations

Lv, Yong, Hui Chen, Bohan Luo, et al.. (2022). Concurrent large spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: A randomized controlled trial. Hepatology. 76(3). 676–688. 44 indexed citations

Wang, Yongji, Yangyang Qi, Yuansheng Hu, et al.. (2020). Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction. Human Vaccines & Immunotherapeutics. 16(10). 2559–2564. 5 indexed citations

Wang, Ling, et al.. (2020). Nomograms predicting survival for all four subtypes of breast cancer: a SEER-based population study. Annals of Translational Medicine. 8(8). 544–544. 14 indexed citations

Xue, Yan, et al.. (2018). A randomized, double blind, controlled, multi center study of Ilaparazole in the treatment of reflux esophagitis—Phase III clinical trial. Contemporary Clinical Trials. 68. 67–71. 2 indexed citations

10.

Wu, Kejian, Haitao Pan, Chen Li, et al.. (2018). An evaluation roadmap for critical quality attributes from tier 1 in analytical similarity assessment. PLoS ONE. 13(12). e0208354–e0208354. 4 indexed citations

11.

Liu, Lei, Yan Zhao, Jia Jia, et al.. (2016). The Prognostic Value of Alpha-Fetoprotein Response for Advanced-Stage Hepatocellular Carcinoma Treated with Sorafenib Combined with Transarterial Chemoembolization. Scientific Reports. 6(1). 19851–19851. 37 indexed citations

12.

Song, Yufei, Yangyang Qi, Chanjuan Li, et al.. (2016). Comparison of immunogenicity and persistence between inactivated hepatitis A vaccine Healive® and Havrix® among children: A 5-year follow-up study. Human Vaccines & Immunotherapeutics. 12(10). 2595–2602. 6 indexed citations

13.

Zhang, Wei, Yujia Kong, Zhiwei Jiang, et al.. (2016). Comprehensive safety assessment of a human inactivated diploid enterovirus 71 vaccine based on a phase III clinical trial. Human Vaccines & Immunotherapeutics. 12(4). 922–930. 10 indexed citations

14.

Zhang, Wei, Zhiwei Jiang, Ling Wang, Chanjuan Li, & Jielai Xia. (2015). An open-label, randomized, multicenter dose-finding study of once-per-cycle pegfilgrastim versus daily filgrastim in Chinese breast cancer patients receiving TAC chemotherapy. Medical Oncology. 32(5). 147–147. 16 indexed citations

15.

Liu, Lei, Hui Chen, Yan Zhao, et al.. (2014). EASL- and mRECIST-Evaluated Responses to Combination Therapy of Sorafenib with Transarterial Chemoembolization Predict Survival in Patients with Hepatocellular Carcinoma. Clinical Cancer Research. 20(6). 1623–1631. 22 indexed citations

16.

Pan, Haitao, Feng Zhang, Ying Yuan, et al.. (2014). The Continual Reassessment Method for Multiple Toxicity Grades: A Bayesian Model Selection Approach. PLoS ONE. 9(5). e98147–e98147. 5 indexed citations

17.

Liu, Xutao, L. Wang, Aidong Wen, et al.. (2012). Ginsenoside‐Rd improves outcome of acute ischaemic stroke – a randomized, double‐blind, placebo‐controlled, multicenter trial. European Journal of Neurology. 19(6). 855–863. 61 indexed citations

18.

Han, Guohong, Xingshun Qi, Wei Zhang, et al.. (2012). Percutaneous Recanalization for Budd-Chiari Syndrome: An 11-year Retrospective Study on Patency and Survival in 177 Chinese Patients from a Single Center. Radiology. 266(2). 657–667. 84 indexed citations

19.

Wang, Suzhen, et al.. (2008). A SAS macro for sample size adjustment and randomization test for internal pilot study. Computer Methods and Programs in Biomedicine. 90(1). 66–88. 4 indexed citations

20.

Wu, Yafei, et al.. (2007). Epidemiology and preventive direction of periodontology in China. Journal Of Clinical Periodontology. 34(11). 946–951. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact